Ensysce Biosciences, Inc. Common Stock (NASDAQ: ENSC) last traded at $0.573, up 2.99% on the session. The quote above updates while this page is open; the figures below are drawn from Ensysce Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Ensysce Biosciences, Inc. Common Stock trades on NASDAQ under the ticker ENSC. Its market capitalisation is $11.14 million.
Valuation measures for Ensysce Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $11.14M |
|---|---|
| Enterprise value | $14.53M |
| Price / sales | 2.47 |
| Beta | 1.14 |
Trailing-twelve-month figures tagged in Ensysce Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $4.50M |
| Net income (TTM) | -$12.62M |
|---|
| Operating margin | -281.32% |
|---|
| Cash | $676.7K |
|---|
Range and volume for ENSC over the past 52 weeks.
| 52-week high | $2.75 |
|---|---|
| 52-week low | $0.230 |
| Volume | 1.20M |
| Average volume | 14.06M |
| Previous close | $0.556 |
Invest a chosen dollar amount in Ensysce Biosciences, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ENSC.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.